Edition:
United States

Catalyst Pharmaceuticals Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

1.25USD
23 Sep 2016
Change (% chg)

-- (--)
Prev Close
$1.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
930,519
52-wk High
$4.18
52-wk Low
$0.51

Analyst Research
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Catalyst Pharmaceuticals Inc (CPRX-O) 25 Sep 2016 Thomson Reuters Stock Report 12 25.00
ValuEngine Rating and Forecast Report for CPRX 24 Sep 2016 ValuEngine, Inc. 11 25.00
Catalyst Pharmaceutical 24 Sep 2016 S&P Capital IQ Quantitative Report 11 127.00
COMPSCRIPT INC (CPRX=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 23 Sep 2016 Pechala's Reports 2 25.00
Catalyst Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 23 Sep 2016 Reuters Investment Profile 12 20.00
Catalyst Pharmaceuticals, Inc. (CPRX) - Financial and Strategic SWOT Analysis Review 18 Sep 2016 GlobalData 61 300.00
Value Graph: CATALYST PHARMA -- CPRX 15 Sep 2016 Ford Investor Services, Inc. 1 12.00
Thomson Reuters Stock Report - Catalyst Pharmaceuticals Inc (CPRX-O) 10 May 2016 Thomson Reuters Stock Report 12 25.00
Catalyst Pharmaceutical Partners, Inc. (CPRX) - Financial and Strategic SWOT Analysis Review 2 May 2016 GlobalData 61 300.00
CPRX.OQ - Event Transcript of Catalyst Pharmaceuticals Inc conference call, Mar. 16, 2016 / 8:30AM ET 16 Mar 2016 Thomson Reuters StreetEvents 7 75.00
 
Name Age Since Current Position

Patrick McEnany

68 2006 Chairman of the Board, President, Chief Executive Officer

Alicia Grande

44 2011 Chief Financial Officer, Vice President, Treasurer

Steven Miller

53 2011 Chief Operating Officer, Chief Scientific Officer

David Muth

60 2015 Executive Vice President, Chief Commercial Officer

M. Douglas Winship

66 2006 Vice President - Regulatory Operations